PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 260 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $612,990 | -30.5% | 21,000 | -4.5% | 0.01% | -22.2% |
| Q2 2023 | $881,540 | -30.2% | 22,000 | -28.9% | 0.01% | -35.7% |
| Q1 2023 | $1,262,988 | -8.4% | 30,948 | -13.4% | 0.01% | -17.6% |
| Q4 2022 | $1,379,535 | -49.4% | 35,730 | -30.3% | 0.02% | -51.4% |
| Q3 2022 | $2,727,000 | -9.1% | 51,264 | -0.3% | 0.04% | -5.4% |
| Q2 2022 | $2,999,000 | -10.5% | 51,442 | +17.2% | 0.04% | +8.8% |
| Q1 2022 | $3,351,000 | +26.8% | 43,910 | +0.0% | 0.03% | +41.7% |
| Q4 2021 | $2,642,000 | +32.5% | 43,908 | +23.3% | 0.02% | +20.0% |
| Q3 2021 | $1,994,000 | +60.0% | 35,613 | +73.5% | 0.02% | +53.8% |
| Q2 2021 | $1,246,000 | +301.9% | 20,527 | +363.9% | 0.01% | +333.3% |
| Q1 2021 | $310,000 | +5066.7% | 4,425 | +4557.9% | 0.00% | – |
| Q4 2020 | $6,000 | – | 95 | +400.0% | 0.00% | – |
| Q3 2017 | $0 | – | 19 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,210,377 | $37,134,366 | 11.77% |
| Gagnon Advisors, LLC | 180,331 | $5,532,555 | 4.63% |
| GAGNON SECURITIES LLC | 565,429 | $17,347,361 | 4.35% |
| ARDSLEY ADVISORY PARTNERS LP | 310,000 | $9,510,800 | 2.12% |
| RICE HALL JAMES & ASSOCIATES, LLC | 968,485 | $29,713,120 | 1.89% |
| AlphaCentric Advisors LLC | 103,000 | $3,160,040 | 1.79% |
| 1492 Capital Management LLC | 79,687 | $2,444,797 | 1.58% |
| ARDSLEY ADVISORY PARTNERS LP | 149,000 | $4,571,320 | 1.02% |
| OUTFITTER FINANCIAL LLC | 32,305 | $991,117 | 0.93% |
| Rock Springs Capital Management LP | 1,055,500 | $32,382,740 | 0.87% |